Drug interactions
Deferasirox + Vincristine
Severity: Minor
Deferasirox and Vincristine: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Deferasirox can induce or alter CYP3A4 activity, which could lower vincristine exposure. Any reduction in efficacy is theoretical and not well documented, and deferasirox also inhibits CYP2C8 and CYP1A2 rather than CYP3A4.
What this interaction means in plain words
Deferasirox and Vincristine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Deferasirox belongs to Miscellaneous; Vincristine belongs to Oncology.
Why it happens
Possible modest CYP3A4 induction by deferasirox may speed vincristine metabolism; the mechanism is not firmly established.
What to do
No routine adjustment is needed; monitor clinical response to vincristine and for unexpected loss of effect.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Deferasirox and Vincristine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Vincristine
- Adenovirus types 4 and 7 live + Vincristine Contraindicated
- Apalutamide + Vincristine Major
- Atazanavir + Vincristine Major
- Ceritinib + Vincristine Major
- Chloramphenicol + Vincristine Major
- Clarithromycin + Vincristine Major
Other interactions of Deferasirox
Frequently asked questions
Can I take Deferasirox with Vincristine?
MediHelp rates the interaction as minor. Deferasirox and Vincristine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Deferasirox can induce or alter CYP3A4 activity, which could lower vincristine exposure. Any reduction in efficacy is theoretical and not well documented, and deferasirox also inhibits CYP2C8 and CYP1A2 rather than CYP3A4.
How serious is the interaction between Deferasirox and Vincristine?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine adjustment is needed; monitor clinical response to vincristine and for unexpected loss of effect.
What other medicines interact with Vincristine?
MediHelp also lists interactions of Vincristine with, for example, Adenovirus types 4 and 7 live, Apalutamide, Atazanavir. The full list is on the Vincristine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
